Lennar Corporation
LEN
$84.97
-1.04%
Lennar Corporation is one of the largest public homebuilders in the United States, operating in the residential construction industry with a core business of constructing and selling homes primarily under the Lennar brand, targeting first-time, move-up, active adult, and luxury homebuyers. The company is a market leader and a vertically integrated operator, distinct for its complementary financial services segment providing mortgage financing and its investments in housing-related technology startups and for-rent construction. The current investor narrative is dominated by the stock's significant underperformance relative to the broader market, driven by persistent headwinds from elevated mortgage rates, affordability challenges, and a sharp decline in profitability, as recent news highlights renewed pressure from geopolitical tensions pushing rates higher and delaying a housing sector recovery.…
LEN
Lennar Corporation
$84.97
Related headlines
Investment Opinion: Should I buy LEN Today?
Rating: Hold. The core thesis is that while Lennar's valuation appears discounted and its balance sheet is robust, near-term fundamental headwinds are too severe and persistent to warrant a Buy rating, making the stock a 'show me' story best suited for watchlists until evidence of stabilization emerges.
Supporting this Hold view are several data points: the forward P/E of 11.6x prices in a significant earnings recovery (consensus EPS $9.55), the EV/Sales of 0.57x suggests a deep discount to sales, and the strong balance sheet (D/E 0.29) provides a margin of safety. However, these are counterbalanced by a 13.1% YoY revenue decline, a gross margin collapse of 400 bps, and a stock price down 28.5% over six months, indicating the negative momentum is grounded in deteriorating fundamentals.
The thesis would upgrade to a Buy if gross margins stabilize above 16% for two consecutive quarters or if the forward P/E compresses below 10x alongside clear signs of a housing market bottom. It would downgrade to a Sell if revenue decline accelerates beyond 15% YoY or if the stock breaks below its 52-week low of $83.03 on high volume. Relative to its own history and the current macro backdrop, the stock is fairly valued—it is not cheap enough to ignore the clear cyclical risks, nor is it so expensive that all bad news is priced in.
Sign up to view all
LEN 12-Month Price Forecast
The outlook is bifurcated and entirely dependent on the path of interest rates and the broader economy. The base case of sideways consolidation is most probable, as the market has priced in a downturn but not a collapse. The strong balance sheet prevents a financial disaster scenario, but the severe margin pressure limits upside until the macro fog clears. The stance would upgrade to bullish on confirmation of sustained gross margin stabilization or a decisive shift in Fed policy toward easing. It would turn bearish on a breakdown below the $83 support level or another quarter of accelerating margin compression.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lennar Corporation's 12-month outlook, with a consensus price target around $110.46 and implied upside of +30.0% versus the current price.
Average Target
$110.46
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$68 - $110
Analyst target range
Analyst coverage for Lennar appears limited in the provided dataset, with only 5 analysts contributing to estimates for revenue and EPS, and no explicit consensus price target, recommendation distribution, or target range provided in the analyst data object. This suggests insufficient analyst coverage is available to form a robust consensus view. The lack of broad, institutional analyst coverage can be typical for companies perceived as cyclical and out of favor, or it may indicate data limitations; this often leads to higher volatility and less efficient price discovery as the stock is more driven by macro sentiment and sector flows than by fundamental analyst scrutiny. The available institutional ratings from recent months show a pattern of neutral to negative sentiment, with firms like Citigroup, UBS, and Wells Fargo maintaining 'Neutral' or 'Equal Weight' stances, while Barclays and Evercore ISI have 'Underweight' or 'Underperform' ratings, indicating a cautious to bearish bias among those who do publish research.
Bulls vs Bears: LEN Investment Factors
The evidence currently tilts bearish, as the fundamental deterioration in revenue and margins is severe, recent, and directly tied to persistent macro headwinds that show no signs of abating. The bull case rests on a valuation that appears cheap and a strong balance sheet, but these are defensive attributes in a storm, not catalysts for near-term outperformance. The single most important tension in the investment debate is the timing and magnitude of a housing market recovery. Bulls argue the current valuation discounts a worst-case scenario, while bears see the margin compression and revenue decline as early indicators of a deeper, more prolonged downturn that the current price does not yet fully reflect.
Bullish
- Strong Balance Sheet, Low Leverage: The company maintains a fortress balance sheet with a debt-to-equity ratio of 0.29, well below typical industry levels, and a robust current ratio of 3.12. This provides significant financial flexibility to navigate the downturn, acquire land opportunistically, and return capital to shareholders without liquidity stress.
- Forward PE Implies Earnings Recovery: The forward P/E of 11.6x, based on analyst consensus EPS of $9.55, is a 29% discount to the trailing P/E of 16.3x. This forward multiple suggests the market has already priced in a significant portion of the current earnings decline and anticipates a meaningful profit recovery in the coming year.
- Sales-Based Valuation at a Discount: The stock trades at a Price-to-Sales ratio of 0.98x and an EV-to-Sales of 0.57x, which are near historical lows for the sector. This valuation disconnect suggests the market is pricing in a prolonged slump, creating a potential margin of safety if the housing cycle shows any signs of stabilization.
- Undersupplied Housing Market Long-Term: Despite near-term headwinds, a structural housing shortage persists in the U.S. As a market leader, Lennar is positioned to benefit from pent-up demand when affordability improves. Its vertical integration and investments in for-rent construction provide diversified avenues for growth beyond the traditional sales cycle.
Bearish
- Severe Profitability Deterioration: Gross margin collapsed to 15.2% in Q1 2026 from 19.2% a year ago, while net margin fell to 3.5% from 6.8%. This 400 bps+ compression in gross margin reflects intense pricing pressure and cost inflation, directly threatening the core investment thesis of stable returns through the cycle.
- Revenue Decline and Demand Weakness: Q1 2026 revenue of $6.62B represents a 13.1% year-over-year decline, confirming a deceleration from the robust growth of fiscal 2024. This top-line contraction, driven by elevated mortgage rates and affordability challenges, signals the cyclical downturn is in full force with no near-term catalyst for reversal.
- Extreme Underperformance vs. Market: The stock has a 1-year relative strength of -47.3% and a 6-month price decline of -28.5%, massively underperforming the S&P 500's 29% gain. This severe technical breakdown reflects a powerful loss of investor confidence and suggests the stock remains in a pronounced downtrend until macro conditions improve.
- High Beta Amplifies Macro Risks: With a beta of 1.49, LEN is nearly 50% more volatile than the market. This high sensitivity means any negative macro news, such as rising mortgage rates or stagflation fears, will disproportionately punish the stock, as evidenced by recent news linking geopolitical tensions to renewed selling pressure.
LEN Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -18.25% and a 6-month decline of -28.54%, significantly underperforming the S&P 500's 29.04% gain over the same period. Currently trading at $88.45, the price sits at approximately 61% of its 52-week range ($83.03 to $144.24), indicating it is closer to its yearly lows than highs, which suggests a value opportunity but also reflects deep-seated fundamental and macroeconomic concerns. Recent momentum shows a modest 1-month gain of 3.52%, which contrasts sharply with the severe 3-month loss of -19.11%, indicating a potential short-term stabilization or oversold bounce within the context of a powerful longer-term downtrend. This divergence may signal a temporary relief rally rather than a trend reversal, especially given the stock's relative strength of -6.46% against the market over the past month. Key technical support is clearly defined at the 52-week low of $83.03, while resistance looms at the 52-week high of $144.24; a breakdown below support would signal a continuation of the bearish trend, whereas a sustained move above the recent April highs near $95 would be needed to suggest a more meaningful base is forming. The stock's beta of 1.487 confirms it is nearly 50% more volatile than the market, which is critical for risk management as it amplifies both downside and potential upside moves in this highly cyclical sector.
Beta
1.42
1.42x market volatility
Max Drawdown
-40.8%
Largest decline past year
52-Week Range
$83-$144
Price range past year
Annual Return
-24.4%
Cumulative gain past year
| Period | LEN Return | S&P 500 |
|---|---|---|
| 1m | -5.4% | +8.2% |
| 3m | -29.7% | +9.0% |
| 6m | -29.8% | +10.5% |
| 1y | -24.4% | +26.5% |
| ytd | -18.5% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LEN Fundamental Analysis
Revenue growth has turned negative, with the most recent Q1 2026 revenue of $6.62 billion representing a year-over-year decline of 13.11%, continuing a multi-quarter deceleration from the robust growth seen in fiscal 2024. The sequential trend from Q4 2025 ($9.37B) to Q1 2026 shows a significant seasonal drop, but the YoY comparison to Q1 2025's $7.62 billion highlights the pressure from slowing housing demand. Profitability has deteriorated markedly, with Q1 2026 net income of $229 million and a net margin of 3.47%, down sharply from the 6.82% net margin in Q1 2025; gross margin compressed to 15.23% from 19.21% a year ago, reflecting pricing pressure and potentially higher construction costs. The company remains profitable, but the trajectory shows significant margin compression, moving away from the double-digit net margins achieved in 2024. The balance sheet remains healthy with a strong current ratio of 3.12 and a conservative debt-to-equity ratio of 0.29, indicating low financial leverage. However, free cash flow generation has weakened, with TTM FCF at $28.2 million, a stark contrast to the $1.67 billion generated in Q4 2025 alone, suggesting the company's ability to internally fund operations and growth is under pressure amid the cyclical downturn.
Quarterly Revenue
$6.6B
2026-02
Revenue YoY Growth
-0.13%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$28183000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LEN Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 16.31x, while the forward PE is 11.62x, indicating the market expects a significant earnings recovery, as the forward multiple prices in the analyst consensus EPS estimate of $9.55 for the coming year. Compared to sector averages, the stock's valuation appears mixed; its trailing PE of 16.3x is not explicitly compared to an industry average here, but its Price-to-Sales ratio of 0.98x and EV-to-Sales of 0.57x suggest a sales-based valuation that may be at a discount to historical norms. The discount on sales multiples likely reflects the market's skepticism about near-term growth and margin prospects. Historically, the stock's own trailing PE has fluctuated significantly, from highs above 30x in early 2026 down to lows near 6.5x in late 2022. The current trailing PE of 16.3x sits below the recent high of 30.47x from February 2026 but above the cyclical lows, suggesting the valuation has de-rated from peak optimism but is not yet at deeply distressed levels, implying the market has priced in a downturn but not a severe collapse.
PE
16.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on collapsing profitability and weak cash generation. The 400 basis point year-over-year gross margin compression to 15.2% is alarming and, if sustained, would cripple earnings power. While the balance sheet is strong (D/E 0.29), Trailing Twelve Month Free Cash Flow has dwindled to just $28.2 million, a stark drop from the $1.67 billion generated in a single quarter previously, indicating the company's ability to self-fund and return capital is under severe pressure. Revenue concentration in the highly cyclical U.S. housing market leaves no natural hedge against a sector-wide slowdown.
Market & Competitive Risks are dominated by macro sensitivity and valuation compression. The stock's high beta of 1.487 confirms it is a leveraged play on interest rates and economic sentiment. Recent news highlights renewed pressure from mortgage rates hitting four-week highs due to geopolitical tensions, directly impacting demand. Trading at a forward P/E of 11.6x, the valuation has de-rated from its 2026 high of over 30x, but remains above the cyclical low near 6.5x seen in late 2022, leaving room for further multiple contraction if the downturn deepens.
Worst-Case Scenario involves a stagflationary environment where high mortgage rates persist alongside slowing economic growth, leading to a multi-year housing recession. In this scenario, revenue declines accelerate, margins compress further, and the stock re-tests its historical valuation lows. The realistic downside from the current price of $88.45 is approximately -6% to the 52-week low of $83.03, but a more severe bear case could see a decline of -25% to -30% if the stock approaches its previous cyclical trough valuation multiples on depressed earnings, implying a price in the low $60s.
FAQ
The key risks are, in order of severity: 1) Macroeconomic & Interest Rate Risk: The stock's high beta (1.49) makes it hypersensitive to mortgage rate moves; further increases would crush demand and margins. 2) Profitability Risk: Gross margin has already fallen from 19.2% to 15.2% YoY; further compression would devastate earnings. 3) Cyclical Downturn Risk: Revenue is declining at a double-digit pace, and the housing cycle could be prolonged. 4) Valuation Compression Risk: If the downturn deepens, the current forward P/E of 11.6x could contract further towards historical lows near 6-7x, leading to significant share price declines even if earnings meet depressed expectations.
Our 12-month forecast outlines three scenarios. The Base Case (50% probability) sees the stock trading between $90 and $105 as the housing market muddles along without a clear recovery, with margins stabilizing. The Bull Case (25% probability) projects a range of $115 to $130, driven by Fed rate cuts and a housing rebound. The Bear Case (25% probability) warns of a drop to $70-$83 if stagflation takes hold and the downturn deepens. The most likely outcome is the Base Case, which assumes the current challenging environment persists but does not catastrophically worsen. The key assumption is that mortgage rates remain elevated but stable, preventing a recovery but also avoiding a meltdown.
LEN appears fairly valued relative to its current challenged fundamentals. Its forward P/E of 11.6x is a discount to its trailing multiple and prices in an expected earnings recovery. Its sales-based multiples (P/S 0.98x, EV/Sales 0.57x) suggest a discount to historical norms. However, this discount is justified by the sharp deterioration in profitability. The valuation implies the market expects a moderate housing slowdown but not a collapse. It is not screamingly undervalued like it was at its 2022 lows, nor is it overvalued relative to its earnings power. In the context of a difficult macro environment, the current price seems like a fair equilibrium.
LEN is not a good buy for most investors at this moment. While its valuation appears cheap with a forward P/E of 11.6x and a strong balance sheet, the company is in the midst of a severe cyclical downturn with revenue declining 13.1% YoY and gross margins collapsing by 400 basis points. The stock has significantly underperformed the market (-47% relative strength over 1 year) for fundamental reasons. It could be a good buy for very patient, risk-tolerant contrarians who believe the housing market will recover sooner and more strongly than expected, but for the average investor, it is a high-risk, 'show me' story best placed on a watchlist.
LEN is unsuitable for short-term trading due to its high volatility (beta 1.49) and sensitivity to unpredictable macro data and Fed commentary, which can cause sharp swings. It is a long-term, cyclical investment for investors with a minimum 2-3 year horizon who are betting on the eventual recovery of the U.S. housing market. The company does pay a small dividend (yield 1.55%), but this is not sufficient for income-focused investors. Given the deep cyclical pressures, only investors willing to endure further potential downside while waiting for the cycle to turn should consider a position, and they should be prepared to hold through multiple quarters of likely weak earnings reports.